In this review:
Emerging strategies for bronchiectasis management
Breathing dysfunction and complex breathlessness in asthma
Bugs behaving badly
Oral antibiotics for non-severe bronchiectasis exacerbations in children
FOT mechanics, from telemonitoring, and symptoms/QOL before acute COPD exacerbations
CF gut microbiome is a major reservoir of transmissible antibiotic resistance
Prognosis of adults with IPF without effective therapies
Patients’ perceptions of opioids for breathlessness in advanced COPD
Clinical response to mepolizumab for severe eosinophilic asthma
Please login below to download this issue (PDF)